Insight into autophagy in platinum resistance of cancer

Int J Clin Oncol. 2023 Mar;28(3):354-362. doi: 10.1007/s10147-023-02301-5. Epub 2023 Jan 27.

Abstract

Platinum drugs, as a class of widely used chemotherapy agents, frequently appear in the treatment of cancer at different phrases. However, platinum resistance is the major bottleneck of platinum drugs for exerting anti-tumor effect. At present, the mechanism of platinum resistance has been thoroughly explored in terms of drug delivery methods, DNA damage repair function, etc., but it has not yet been translated into an effective weapon for reversing platinum resistance. Recently, autophagy has been proved to be closely related to platinum resistance, and the involved molecular mechanism may provide a new perspective on platinum resistance. The aim of this review is to sort out the studies related to autophagy and platinum resistance, and to focus on summarizing the relevant molecular mechanisms, so as to provide clues for future studies related to autophagy and platinum resistance.

Keywords: Autophagy; Cancer; Cytoprotective; Cytotoxic; DNA repair; Platinum resistance.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Autophagy
  • Drug Resistance, Neoplasm
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Platinum / pharmacology
  • Platinum / therapeutic use

Substances

  • Platinum
  • Antineoplastic Agents